Cargando…

Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era

We measured severe acute respiratory syndrome coronavirus 2 immunoglobulin G responses in 67 patients with hematological malignancies after 2 messenger RNA vaccine doses. Forty-six percent were nonresponders; patients with B-cell chronic lymphocytic leukemia were at highest risk (77% nonresponders)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Agha, Mounzer E, Blake, Maggie, Chilleo, Charles, Wells, Alan, Haidar, Ghady
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320282/ https://www.ncbi.nlm.nih.gov/pubmed/34337100 http://dx.doi.org/10.1093/ofid/ofab353

Ejemplares similares

Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients
por: Agha, Mounzer, et al.
Publicado: (2021)

Improving the Outcomes of Immunocompromised Patients With Coronavirus Disease 2019
por: Haidar, Ghady, et al.
Publicado: (2021)

Coronavirus Disease 2019 (COVID-19), Organ Transplantation, and the Nuances of Immunomodulation: Lessons Learned and What Comes Next
por: Haidar, Ghady
Publicado: (2020)

Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review
por: Campbell, Courtney M., et al.
Publicado: (2020)

Distinct temporal integration of noradrenaline signaling by astrocytic second messengers during vigilance
por: Oe, Yuki, et al.
Publicado: (2020)

1105. The Burden of Infections Prior to Chimeric Antigen Receptor (CAR) Modified T-cell Therapy Predicts Post-CAR T-cell Infectious Complications
por: Garner, Will, et al.
Publicado: (2020)

202. The Impact and Safety of Discontinuing Routine Surveillance Blood Culture Monitoring in Allogeneic Hematopoietic Cell Transplant Recipients
por: Garner, Will, et al.
Publicado: (2021)

Author Correction: Distinct temporal integration of noradrenaline signaling by astrocytic second messengers during vigilance
por: Oe, Yuki, et al.
Publicado: (2020)

Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals
por: Collier, Ai-ris Y, et al.
Publicado: (2021)

Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2–Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients
por: Haidar, Ghady, et al.
Publicado: (2023)

Destroying the messenger
por: Wells, William A.
Publicado: (2007)

Electrophysiology in the Era of Coronavirus Disease 2019
por: Kanthasamy, Vijayabharathy, et al.
Publicado: (2020)

Cyber-vigilance and digital trust: cybersecurity in the era of cloud computing and IoT
por: Tounsi, Wiem
Publicado: (2019)

Commentary: The SINE of the times—vigilance in the era of frozen elephant trunk procedures
por: Arnaoutakis, George J., et al.
Publicado: (2021)

Immune parameters during anaphylaxis to messenger RNA coronavirus disease 2019 vaccines: Not the usual suspects?
por: de Chaisemartin, Luc, et al.
Publicado: (2022)

Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent Adults
por: Florea, Ana, et al.
Publicado: (2022)

Vigilance needed with methamphetamine-associated psychosis
por: Elefante, Raymond Julius O., et al.
Publicado: (2023)

Don't digest the messenger
por: Wells, William A.
Publicado: (2004)

Home Dialysis in the Coronavirus Disease 2019 Era
por: Yerram, Preethi, et al.
Publicado: (2020)

Immunity to a third BNT162B2 COVID-19 vaccine after heart transplantation: Bridging the knowledge gap to end the pandemic for organ transplant recipients
por: Haidar, Ghady
Publicado: (2022)

Evaluation of anaphylaxis risk by skin testing with coronavirus disease 2019 messenger RNA vaccines on patients with anaphylaxis
por: Pienkowski, Marek M., et al.
Publicado: (2022)

Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age
por: Das, Bibhuti B., et al.
Publicado: (2021)

Coronavirus disease 2019 messenger RNA vaccine skin tests and serum histamine levels in allergic reactions
por: Kohli-Pamnani, Anita, et al.
Publicado: (2022)

Long-term evaluation of sperm parameters after coronavirus disease 2019 messenger ribonucleic acid vaccination
por: Diaz, Parris, et al.
Publicado: (2022)

Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination—A nationwide study
por: Su, Wei-Ju, et al.
Publicado: (2023)

Hematological findings in coronavirus disease 2019: indications of progression of disease
por: Liu, Xiaoqing, et al.
Publicado: (2020)

Eternal Vigilance
Publicado: (1900)

Thyroid Vigilance
por: Kalra, Sanjay, et al.
Publicado: (2017)

Proteus syndrome: More vigilance needed to diagnose it
por: Angurana, Suresh Kumar, et al.
Publicado: (2014)

Disproportionality analysis of anaphylactic reactions after vaccination with messenger RNA coronavirus disease 2019 vaccines in the United States
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2021)

Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions
por: Pitlick, Mitchell M., et al.
Publicado: (2022)

Acute pulmonary thromboembolism after messenger RNA vaccination against coronavirus disease 2019: A case report
por: Ishibashi, Yohei, et al.
Publicado: (2023)

Laparoscopy in the coronavirus disease 2019 (COVID-19) era
por: Angioni, Stefano
Publicado: (2020)

Patients with cancer in the era of 2019 novel coronavirus disease
por: Hartemink, Koen J., et al.
Publicado: (2020)

Masked Tardive Dyskinesia in the Coronavirus Disease 2019 Era
por: Laboe, Christopher, et al.
Publicado: (2021)

Ophthalmology Education in the Post-Coronavirus Disease 2019 Era
por: Zarei-Ghanavati, Mehran, et al.
Publicado: (2020)

Hematology profile analysis in coronavirus disease 2019 (COVID-19) patients
por: Setio, Felisia, et al.
Publicado: (2022)

Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 Vaccine( )
por: Maron, Jenny S, et al.
Publicado: (2022)

Cyclophosphamide-induced toxic epidermal necrolysis: vigilance needed
por: Patel, Mohan P., et al.
Publicado: (2014)

Revisiting the Need for Vigilance Concerning Children and International Travel
por: Stanton, Bonita F.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m01l31on7s6i0o6dp2avvd1607